Company News
New tool plays a critical role in supporting complex multiomic research initiatives by helping scientists design and execute customized statistical analyses.
MORRISVILLE, N.C. – September 17, 2024 – Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the much-anticipated launch of an advanced statistical analysis tool within the company’s bioinformatics platform.
Researchers handling large sample datasets struggle to filter out unnecessary data and focus on what’s critical. Metabolon’s new statistical analysis tool helps researchers build and compare different statistical models, upload and manage metadata, remove outliers, test hypotheses, and visualize results with the goal of uncovering new multiomic insights that might be missed with raw data alone.
“As your research expands, this new statistical tool supports further hypothesis testing and advanced analyses like outlier removal, modifying metadata, and running statistical tests such as T-tests and ANOVAs, all through an easy, step-by-step process,” said Ro Hastie, President & CEO at Metabolon. “Designed by popular demand and with significant customer input, we’re confident researchers will love the power and fidelity of Metabolon’s new statistical analysis tool!”
Metabolon’s new statistical analysis tool includes the following functionality:
To learn more about Metabolon’s Integrated Bioinformatics Platform, please visit: https://www.metabolon.com/bioinformatics/
Metabolomics, the large-scale study of all small molecules in a biological system, is the only omics technology that provides a complete current-state functional readout of a biological system. Metabolomics helps researchers see beyond individual genetic variation, capturing the combined impact of genetic and external factors, such as drugs, diet, lifestyle, and the microbiome, on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug’s mechanism of action, pharmacodynamics, and safety profile, as well as individual responses to therapy.
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other ‘omics’ technologies. With 25 years of experience, 15,000+ client projects, 4,000+ scientific publication references, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques.
Metabolon’s Global Discovery Panel is powered by the world’s largest proprietary metabolomics reference library. Metabolon’s industry-leading data and translational science expertise help customers and partners address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success. The company offers scalable, customizable multiomics solutions, including metabolomics and lipidomics, that support customer needs from discovery through clinical trials and product life-cycle management.
For more information, please visit metabolon.com and follow us on LinkedIn and Twitter.
Sean Iverson
VP, Global Marketing
siverson@metabolon.com
Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
Mailing Address
P.O. Box 110407
Research Triangle Park, NC 27709
Phone
+1 (919) 572-1711
Fax
+1 (919) 572-1721
International Headquarters
Metabolon GmbH
Zeppelinstraße 3
85399 Hallbergmoos
Germany